British HIV Association and Children's HIV Association guidelines for the management of HIV infection in pregnant women 2008

6 Embryonic/foetal toxicity 11.6.1 Didanosine 11.6.2Efavirenz 11.6.3Management of women who conceive on efavirenz 12.0 Antiretroviral therapy and pregnancy: pharmacokinetics (Recommendation Grade C/Level IV) 13.0 Obstetric management of pregnancy and delivery (Recommendation Grades A-C/Levels Ib-IV) 13.1 Antenatal care 13.2 Early pregnancy problems 13.2.1 Nausea and vomiting 13.2.2Bleeding in early pregnancy 13.2.3Prenatal diagnosis 13.3 Complications of later pregnancy 13.3.1 Problems associated with HIV 13.3.2Medical disorders of pregnancy 13.3.3Antepartum haemorrhage 13.3.4Pre-term labour 13.3.5Pre-term pre-labour rupture of membranes at gestations 434 weeks 13.3.6Pre-term pre-labour rupture of membranes at gestations o34 weeks 13.3.7 Term pre-labour rupture of membranes 13.3.8Prolonged pregnancy 13.3.9Vaginal birth after Caesarean 13.4 Management of delivery 13.4.1 Mode of delivery 13.4.2Management of Caesarean section 13.4.3Management of vaginal delivery 13.5 Postpartum care 13.5.1 Suppression of lactation 13.5.2Contraception 14.0 Pregnancy in women with HIV-2 infection 14.1 Mode of delivery Guidelines for the management of HIV infection in pregnant women 453